Recursion Pharmaceuticals

The $4B AI drug discovery company with a landmark $50M NVIDIA partnership. Recursion has screened 2,000+ compounds using its biological foundation model, compressing the early-stage drug discovery timeline from years to weeks -- 80% faster than the typical biotech rival. This efficiency enables 5x more candidates per year than traditional methods.